These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27239517)

  • 21. Disfluency patterns in Alzheimer's disease and frontotemporal lobar degeneration.
    Pistono A; Pariente J; Jucla M
    Clin Linguist Phon; 2024 Apr; 38(4):345-358. PubMed ID: 36004675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion.
    Junttila A; Kuvaja M; Hartikainen P; Siloaho M; Helisalmi S; Moilanen V; Kiviharju A; Jansson L; Tienari PJ; Remes AM; Herukka SK
    Dement Geriatr Cogn Dis Extra; 2016; 6(1):142-9. PubMed ID: 27195002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
    Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.
    Verwey NA; Kester MI; van der Flier WM; Veerhuis R; Berkhof H; Twaalfhoven H; Blankenstein MA; Scheltens And P; Pijnenburg YA
    J Alzheimers Dis; 2010; 20(2):445-52. PubMed ID: 20164558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives.
    Oeckl P; Steinacker P; Feneberg E; Otto M
    Biochim Biophys Acta; 2015 Jul; 1854(7):757-68. PubMed ID: 25526887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.
    Paraskevas GP; Kasselimis D; Kourtidou E; Constantinides V; Bougea A; Potagas C; Evdokimidis I; Kapaki E
    J Alzheimers Dis; 2017; 55(4):1453-1461. PubMed ID: 27858708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
    Balasa M; Sánchez-Valle R; Antonell A; Bosch B; Olives J; Rami L; Castellví M; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2014; 40(4):919-27. PubMed ID: 24577466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
    Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
    J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.
    Oeckl P; Steinacker P; von Arnim CA; Straub S; Nagl M; Feneberg E; Weishaupt JH; Ludolph AC; Otto M
    J Proteome Res; 2014 Nov; 13(11):4518-25. PubMed ID: 25091646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.
    Borroni B; Benussi A; Archetti S; Galimberti D; Parnetti L; Nacmias B; Sorbi S; Scarpini E; Padovani A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):86-91. PubMed ID: 25352065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease.
    Courtemanche H; Bigot E; Pichelin M; Guyomarch B; Boutoleau-Bretonnière C; Le May C; Derkinderen P; Cariou B
    J Alzheimers Dis; 2018; 62(4):1519-1525. PubMed ID: 29562508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry.
    Frings L; Mader I; Landwehrmeyer BG; Weiller C; Hüll M; Huppertz HJ
    Hum Brain Mapp; 2012 Jul; 33(7):1526-35. PubMed ID: 21618662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
    Kapaki E; Paraskevas GP; Papageorgiou SG; Bonakis A; Kalfakis N; Zalonis I; Vassilopoulos D
    Alzheimer Dis Assoc Disord; 2008; 22(1):47-53. PubMed ID: 18317246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Correlates of Alzheimer's Disease Cerebrospinal Fluid Analytes in Primary Progressive Aphasia.
    Norise C; Ungrady M; Halpin A; Jester C; McMillan CT; Irwin DJ; Cousins KA; Grossman M
    Front Neurol; 2019; 10():485. PubMed ID: 31133977
    [No Abstract]   [Full Text] [Related]  

  • 39. Behavioral and activities of daily living inventories in the diagnosis of frontotemporal lobar degeneration and Alzheimer's disease.
    Bahia VS; da Silva MM; Viana R; Smid J; Damin AE; Radanovic M; Nitrini R
    Dement Neuropsychol; 2008; 2(2):108-113. PubMed ID: 29213552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.
    Lauridsen C; Sando SB; Shabnam A; Møller I; Berge G; Grøntvedt GR; Bakken IJ; Salvesen Ø; Bråthen G; White LR
    Front Aging Neurosci; 2016; 8():30. PubMed ID: 26973507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.